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he HIV-1 Gag protein recruits the cellular factor
Tsg101 to facilitate the ﬁnal stages of virus budding.
A conserved P(S/T)AP tetrapeptide motif within Gag
(the “late domain”) binds directly to the NH
 
2
 
-terminal
ubiquitin E2 variant (UEV) domain of Tsg101. In the cell,
Tsg101 is required for biogenesis of vesicles that bud into
the lumen of late endosomal compartments called multi-
vesicular bodies (MVBs). However, the mechanism by
which Tsg101 is recruited from the cytoplasm onto the
endosomal membrane has not been known. Now, we report
that Tsg101 binds the COOH-terminal region of the endo-
T
 
somal protein hepatocyte growth factor–regulated tyrosine
kinase substrate (Hrs; residues 222–777). This interaction is
mediated, in part, by binding of the Tsg101 UEV domain to
the Hrs 
 
348
 
PSAP
 
351
 
 motif. Importantly, Hrs
 
222–777
 
 can recruit
Tsg101 and rescue the budding of virus-like Gag particles
that are missing native late domains. These observations
indicate that Hrs normally functions to recruit Tsg101 to
the endosomal membrane. HIV-1 Gag apparently mimics
this Hrs activity, and thereby usurps Tsg101 and other com-
ponents of the MVB vesicle ﬁssion machinery to facilitate
viral budding.
 
Introduction
 
The HIV Gag protein orchestrates viral assembly and budding,
and forms the structural shell of the immature virus (for review
see Göttlinger, 2001). Even in the absence of any other viral
proteins, HIV-1 Gag can form extracellular virus-like particles
(VLPs) that resemble authentic HIV virions. Efficient release
of HIV-1 virions and Gag VLPs from most cell types requires
the presence of a “late domain” located in the COOH-terminal
Gag p6 region (Göttlinger et al., 1991; Huang et al., 1995;
Demirov et al., 2002b). All HIV-1 strains contain the late
domain tetrapeptide motif P(S/T)AP (where the second
position can be either Ser or Thr; Fig. 1), which is a docking
site for the cellular protein, tumor susceptibility gene 101
(Tsg101; for review see Pornillos et al., 2002c). Tsg101 appears
to facilitate viral budding by recruiting additional cellular
factors that can catalyze release of the enveloped virion. In
addition to the P(S/T)AP sequence found in HIV-1 Gag,
distinct late domain sequences have also been identified and
characterized in several other enveloped RNA viruses. The
best characterized of these is the PPXY motif (where X is
any amino acid), which binds the Nedd4 protein family of
ubiquitin E3 ligases (Xiang et al., 1996; Harty et al., 1999,
2001; Strack et al., 2000; Kikonyogo et al., 2001; Yasuda et
al., 2002; Timmins et al., 2003).
The P(S/T)AP late domains of HIV-1, HIV-2, and Ebola
virus bind to the NH
 
2
 
-terminal ubiquitin E2 variant (UEV)
domain of Tsg101 (Garrus et al., 2001; Martin-Serrano et
al., 2001; VerPlank et al., 2001; Demirov et al., 2002a; Myers
and Allen, 2002; Pornillos et al., 2002b; Timmins et al.,
2003). UEV domains also bind ubiquitin and are structurally
related to ubiquitin E2–conjugating enzymes, but lack the
active site cysteine residue required for ubiquitin transfer
(Moraes et al., 2001; VanDemark et al., 2001; Pornillos et
al., 2002a). Tsg101 UEV also differs from the canonical E2
enzymes in that it displays a hydrophobic groove that specifi-
cally recognizes P(S/T)AP sequences (Pornillos et al., 2002a).
All four P(S/T)AP residues are required for late domain activity
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(Huang et al., 1995), and all four make important contacts
within the Tsg101 UEV binding site (Pornillos et al.,
2002a,b). However, despite this sequence specificity, the
Tsg101 UEV domain presumably did not evolve to bind vi-
ral P(S/T)AP sequences, and it is therefore reasonable to
speculate that the Tsg101 UEV domain may bind P(S/T)AP
elements found in cellular proteins.
In the cell, Tsg101 (yeast Vps23p) normally functions as a
subunit of the endosomal sorting complex required for
transport-I (ESCRT-I) protein complex (Katzmann et al.,
2001). Tsg101 and ESCRT-I perform essential roles in the
vacuolar protein sorting (Vps) pathway, in which integral
membrane proteins such as cell surface receptors are targeted
for destruction in the lysosome (for review see Katzmann et
al., 2002). In this pathway, monoubiquitylated proteins are
delivered to endosomal membranes where they are sorted
into microdomains that ultimately bud as small vesicles into
late endosomal compartments to form multivesicular bodies
(MVBs). MVBs can then fuse with lysosomes and release
these vesicles and their protein cargos into the lumen of the
lysosome, where they are degraded by hydrolases and lipases.
ESCRT-I is one of a series of soluble protein complexes
that are recruited from the cytoplasm onto the surface of the
endosome during MVB biogenesis. Once on the membrane,
Tsg101/ESCRT-I appears to perform at least two essential
functions: (1) it binds ubiquitylated cargo proteins via direct
interactions between the Tsg101 UEV domain and the ubiq-
uitin modifications (Katzmann et al., 2001); and (2) it helps
to recruit the downstream ESCRT-II, ESCRT-III, Vps4,
and other proteins and complexes required to complete pro-
tein sorting and vesicle formation (Babst et al., 2002a,b).
Thus, recruitment of Tsg101 to the membrane surface repre-
sents a key step in the commitment to vesicle formation.
However, the mechanism by which Tsg101/ESCRT-I is re-
cruited to the membrane has not been elucidated.
Although interactions between Tsg101 and cellular P(S/
T)AP motifs have not been described, we reasoned that such
interactions might occur and play a role in the recruitment
of Tsg101 to the endosomal membrane. Protein database
searches revealed several Vps proteins with PTAP or PSAP
motifs (Garrus et al., 2001), including (1) Tsg101 itself; and
(2) hepatocyte growth factor–regulated tyrosine kinase sub-
strate (Hrs; yeast Vps27p; Raiborg et al., 2001a; Raiborg
and Stenmark, 2002). Hrs is an attractive candidate for the
factor that recruits Tsg101 to endosomal membranes be-
cause it is required for receptor down-regulation and MVB
biogenesis (Piper et al., 1995; Odorizzi et al., 1998; Lloyd et
al., 2002; Shih et al., 2002; Bache et al., 2003b) and because
it interacts with ubiquitylated cargo proteins on the early en-
dosome (and therefore appears to function upstream of
Tsg101; Bilodeau et al., 2002; Bishop et al., 2002; Raiborg
et al., 2002; Bache et al., 2003b).
The domain organization and biochemical properties of
the Hrs and HIV-1 Gag proteins exhibit several intriguing
similarities (Fig. 1). First, both proteins contain amino-
proximal membrane-targeting domains. In HIV-1 Gag, the
N-myristoylated MA domain binds membranes, and con-
tains signals that target Gag to the plasma membrane in
some cell lines (Göttlinger, 2001; Raposo et al., 2002;
Pelchen-Matthews et al., 2003). In Hrs, the FYVE domain
binds PI(3)P and thereby targets Hrs to endosomal mem-
branes (Komada et al., 1997; Odorizzi et al., 1998; Raiborg
et al., 2001b; Katzmann et al., 2003). Second, both proteins
contain P(S/T)AP motifs within proline-rich (and appar-
ently unstructured) regions. Third, both Hrs and HIV-1
Gag proteins are monoubiquitylated. Although a functional
role for HIV Gag ubiquitylation in retrovirus budding has
not been demonstrated, ubiquitin transfer is important for
virus budding (for review see Vogt, 2000), and viral late do-
mains have been shown to recruit ubiquitin ligase activities
(Strack et al., 2000, 2002). Hrs ubiquitylation is essential for
receptor down-regulation through the MVB pathway, and
requires a cis-acting sequence motif called the ubiquitin-
interacting motif (UIM; Young et al., 1998; Hofmann and
Falquet, 2001; Bishop et al., 2002; Lloyd et al., 2002; Polo
et al., 2002; Raiborg et al., 2002; Shih et al., 2002). Other
UIM-containing proteins are substrates for the Nedd4 (yeast
Rsp5p) family of ubiquitin ligases (Katz et al., 2002; Polo et
al., 2002), and although it is not yet known whether Nedd4
ubiquitylates Hrs, the protein does harbor a PPEY motif.
This sequence matches the consensus sites for cellular
Nedd4 substrates and for PPXY viral late domains (Rotin et
al., 2000; Freed, 2002; Pornillos et al., 2002c).
The preceding observations are consistent with a model in
which (1) Tsg101 is normally recruited to the endosomal mem-
brane through a direct interaction with Hrs; and (2) the HIV-1
Gag protein has evolved to mimic the Tsg101-recruiting func-
tions of Hrs, and thereby redirect the machinery of MVB vesi-
cle formation to sites of viral budding on the plasma mem-
brane. Experiments described in this paper were designed to test
key aspects of these models for Hrs function and viral mimicry.
 
Results
 
Tsg101 UEV binds the P(S/T)AP motifs from HIV-1 
Gag, Tsg101, and Hrs
 
First, we tested whether the UEV domain of Tsg101 could
bind to isolated P(S/T)AP motifs from HIV-1
 
NL4–3
 
 Gag and
from the human Tsg101 and Hrs proteins. The Tsg101
UEV binding epitope is small, and the domain binds with
the same affinity to a nine-amino acid peptide as to the in-
Figure 1. Domain organization of the HIV-1 Gag and human 
Tsg101 and Hrs proteins. The HIV Gag and Hrs proteins are aligned 
to emphasize their similarities, with the NH2-terminal membrane-
binding domains separated from the COOH-terminal protein–protein 
interaction domains by a vertical dashed line. UEV, ubiquitin E2 
variant; PRD, proline-rich domain; COIL, putative coiled-coil; SBOX, 
“steadiness box/Vps28 binding site” (Feng et al., 2000). Locations of 
P(S/T)AP and PPEY motifs are also indicated.T
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tact HIV-1 p6 protein (
 
 
 
25 
 
 
 
M; Pornillos et al., 2002b).
Therefore, 10-amino acid peptides spanning the central P(S/
T)AP motifs from Gag, Tsg101, and Hrs were tested for
Tsg101 UEV domain binding in BIAcore biosensor experi-
ments. As expected, Tsg101 UEV exhibited concentration-
dependent binding to the Gag PTAP peptide, and the equi-
librium responses fit a simple 1:1 binding model with a
dissociation constant (K
 
d
 
20
 
 
 
C
 
) of 21 
 
 
 
 1 
 
 
 
M (Fig. 2). This
interaction was specific, as the Tsg101 UEV domain did not
bind to a control peptide in which the second Pro residue in
the PTAP motif was mutated to Leu (Fig. 2).
The Tsg101 UEV domain also bound to P(S/T)AP pep-
tides from Tsg101 and from Hrs (Fig. 2). However, the
binding affinities were fourfold (Tsg101) and sevenfold
(Hrs) weaker than Tsg101 UEV binding to the HIV-1
PTAP peptide. Hence, the Tsg101 UEV domain can bind
the P(S/T)AP motifs of all three proteins, but sequences
flanking the central P(S/T)AP motif can modulate the abso-
lute binding affinities significantly. Indeed, we have exam-
ined some isolated P(S/T)AP peptide sequences that exhib-
ited almost undetectable Tsg101 UEV binding (Fisher, R.,
personal communication).
 
Interaction of full-length Tsg101 and Hrs proteins
 
The interaction of full-length Tsg101 and wild-type Hrs
proteins was examined in directed yeast two-hybrid assays.
Plasmids expressing a Tsg101–Gal4p binding domain fu-
sion (Tsg101-BD) and an Hrs–Gal4p activation domain fu-
sion (Hrs-AD) were cotransfected into the reporter yeast
strain J693, resulting in significant levels of 
 
 
 
-galactosidase
activity (Fig. 3 A, top left). In contrast, control experiments
in which one of the two plasmids encoded only the Gal4p
BD or AD alone did not produce significant 
 
 
 
-galactosidase
 
activity (Fig. 3 A). Similarly, in semi-quantitative liquid
culture assays, the binding of full-length Hrs-AD to full-
length Tsg101-BD typically stimulated 
 
 
 
-galactosidase ac-
tivity 
 
 
 
100-fold above background (Fig. 3, B–D). There-
fore, we conclude that the full-length Tsg101 and Hrs pro-
teins interact in the yeast two-hybrid assay.
 
Requirements for Tsg101/Hrs binding
 
Based on the known binding properties of the Tsg101 UEV
domain, we hypothesized that Tsg101 might interact with
Hrs via (1) an interaction between the Tsg101 UEV domain
and the Hrs PSAP motif; and/or (2) an interaction between
the Tsg101 UEV domain and a ubiquitin modification on
Hrs. Tsg101 UEV binds P(S/T)AP peptides and ubiquitin at
different sites, and distinct Tsg101 point mutations eliminate
PTAP (M95A) or Ub (N45A) binding (Pornillos et al.,
2002a). Therefore, these mutations were tested for their effects
on the Tsg101/Hrs two-hybrid interaction (Fig. 3, B and C).
The ubiquitin-binding mutation in Tsg101 UEV (N45A)
had no effect on the Hrs/Tsg101 interaction (Fig. 3 B). Like-
wise, alanine substitutions in the Hrs PPEY sequence had no
significant effect on Tsg101/Hrs binding (unpublished data).
These experiments indicated that the Tsg101/Hrs two-
hybrid interaction was not mediated through ubiquitin.
In contrast, the PSAP-binding mutation in Tsg101
(M95A) reduced Hrs binding significantly (approximately
sixfold; Fig. 3 C). In complementary experiments, alanine
substitution of the Hrs 
 
348
 
PSAP
 
351
 
 sequence (Hrs
 
 
 
PSAP
 
) also
reduced wild-type Tsg101 binding, albeit to a lesser extent
(approximately twofold). The greater reduction in binding
seen for the Tsg101 M95A mutation may reflect weak
Tsg101 UEV binding to several additional PSAP-like motifs
(
 
583
 
PSGP
 
586
 
 and 
 
620
 
PSMP
 
623
 
) that are conserved from hu-
man Hrs to yeast Vps27p (Emr, S., personal communica-
tion). As expected, the Hrs
 
 
 
PSAP
 
 mutation did not further re-
duce binding of the Tsg101 M95A mutation, consistent
with the idea that these mutations affected the two sides of
the same protein–protein interface.
Surprisingly, even in the absence of the Tsg101 UEV/Hrs
PSAP interaction, Hrs and Tsg101 exhibited significant re-
sidual binding. Therefore, directed two-hybrid experiments
were used to define the complete Hrs region required for full
affinity binding. As summarized in Fig. 3 D, Tsg101 did not
bind the NH
 
2
 
-terminal VHS and FYVE domains of Hrs (res-
idues 1–221). These domains were also completely dispens-
able for the Tsg101/Hrs interaction, as Tsg101 bound
equally well to a COOH-terminal fragment spanning resi-
dues 222–777 (Hrs
 
 
 
N
 
) as to full-length Hrs. In contrast, dele-
tion of COOH-terminal Hrs residues 565–777 reduced (but
did not eliminate) Hrs binding, and a further six-amino acid
deletion that removed the entire COOH-terminal Pro/Gln-
rich region of Hrs (Hrs
 
 
 
N
 
 
 
C
 
; Hrs residues 222–559) reduced
Tsg101 binding to nearly background levels. A murine Hrs
construct (residues 287–573) that extended 
 
 
 
15 residues
into the Pro/Gln-rich region bound well (Bache et al.,
2003a), and we therefore conclude that Hrs residues 560–
573 contribute to Tsg101 binding. Tsg101 bound only
weakly (or not at all) to a series of smaller Hrs fragments that
spanned just the Hrs PSAP element (e.g., Hrs 1–450) or the
coiled-coil Pro/Gln-rich region (e.g., Hrs 451–777; see Fig. 3
Figure 2. The Tsg101 UEV domain binds the P(S/T)AP motifs from 
HIV-1 Gag, Tsg101, and Hrs. Biosensor binding isotherms showing 
the concentration-dependent binding of purified recombinant Tsg101 
UEV domain to immobilized fusion peptides spanning the P(S/T)AP 
motifs of HIV-1 Gag, Tsg101, and Hrs, as well as a mutant form of the 
HIV-1 Gag PTAP motif (negative control). Solid lines show the optimal 
fits to simple 1:1 binding models used to obtain binding affinities. 
Note that substitution of S for T at the second position of the P(S/T)AP 
motif does not significantly affect the Tsg101 binding affinity (not 
depicted), but that sequences flanking the central P(S/T)AP 
tetrapeptides can modulate Tsg101 binding affinity significantly.T
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D). Thus, we conclude that full affinity Tsg101 binding re-
quires the presence of two (or more) different Hrs regions:
(1) the PSAP motif; and (2) a second region spanning the pu-
tative coiled-coil and at least part of the Pro/Gln-rich region.
 
Hrs late domain activity
 
Next, we tested whether the protein-recruiting functions of
Hrs were sufficient to support the budding of VLPs from
cultured human cells. Expression of HIV Gag–GFP fusion
proteins in human cell lines recapitulates many aspects of vi-
ral assembly and budding (Hermida-Matsumoto and Resh,
2000), including the requirement for Tsg101 and other
components of the MVB pathway (Garrus et al., 2001).
Human embryonic kidney 293T cells were transfected
with HIV Gag expression constructs, and analyzed for pro-
tein expression and for VLP release 24–28 h later (Fig. 4).
VLP release was analyzed by Western blotting of culture su-
pernatants after sucrose cushion pelleting (Fig. 4, B and C;
VLP). Intracellular Gag protein expression levels were ana-
lyzed in Western blots of cytoplasmic extracts (Fig. 4, B and
C; Cell). As expected, the control Gag–GFP fusion protein
expressed well and formed VLPs efficiently (Fig. 4 B, lane 1;
Hermida-Matsumoto and Resh, 2000; Garrus et al., 2001).
VLP release was dependent on the presence of a functional
 
PTAP late domain, as mutation of the PTAP motif to LIRL
(Gag
 
 
 
PTAP
 
–GFP; Fig. 4 B, lane 2) severely attenuated parti-
cle release (Göttlinger et al., 1991; Huang et al., 1995; Gar-
rus et al., 2001).
To test whether the protein recruitment activities of Hrs
could replace the late domain activity of the cis-acting Gag
PTAP motif, the GFP polypeptide of Gag
 
 
 
PTAP
 
-GFP was
replaced with the Hrs
 
 
 
N
 
 polypeptide (denoted Gag
 
 
 
PTAP
 
–
Hrs
 
 
 
N
 
; Fig. 4 A). As described in the previous section, the
Hrs
 
 
 
N
 
 fragment is missing the NH
 
2
 
-terminal domains that
normally target Hrs to the endosomal membrane, but con-
tains both the 
 
348
 
PSAP
 
351
 
 motif and the Pro/Gln-rich region,
and binds Tsg101 (Fig. 3 D). As shown in Fig. 4 B (top,
lane 3), the Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 fusion protein was efficiently
released into the culture supernatant. Indeed, the late do-
main activity of the Hrs
 
 
 
N
 
 polypeptide (51% of total Gag
protein released) was nearly as strong as the native Gag
PTAP motif (57% of total Gag protein released). The Hrs
 
 
 
N
 
construct also rescued particle release when fused to a Gag
protein that was missing the entire p6 domain (Gag
 
 
 
p6
 
, un-
published data and see below).
Analogous results were obtained in experiments designed
to test whether Gag–Hrs fusion proteins could rescue the
budding of defective Gag constructs in trans (Fig. 4 C). This
Figure 3. Hrs/Tsg101 yeast two-hybrid binding assays. (A) Filter paper colony 
lift assay for  -galactosidase reporter gene activity. Yeast cells were cotrans-
formed with pairs of plasmids expressing the indicated Gal4 DNA-binding domain 
(BD) and activation domain (AD) fusion constructs. Cells were grown on 
synthetic agar media lacking the appropriate amino acids and were analyzed for 
 -galactosidase activity (blue) as described in Materials and methods. (B) Binding 
of Hrs to wild-type and mutant (N45A) Tsg101. Binding experiments in B–D show 
yeast two-hybrid interactions (together with appropriate controls) as measured in 
semi-quantitative CPRG  -galactosidase activity assays. Bars depict the average 
absorbance (595 nm) and SDs from three independent measurements. (C) Binding 
of wild-type and mutant ( PSAP) Hrs to wild-type and mutant (M95A) Tsg101. 
(D) Binding of Tsg101 to Hrs deletion mutants.T
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experiment took advantage of the fact that defective Gag
proteins can be released from cells by co-assembling with
Gag proteins that are competent for budding (Martin-Ser-
rano et al., 2001). Control experiments demonstrated that
 
wild-type Gag–GFP could rescue the release of Gag
 
 
 
p6
 
 when
the two proteins were coexpressed in the same cell (Fig. 4 C,
top, compare lane 1 and lane 2), and that rescue required the
Gag–GFP PTAP sequence (Fig. 4 C, top, compare lane 2
and 3). Gag
 
 
 
p6
 
 release was also efficiently rescued in trans by
coexpression with Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 (Fig. 4 C, top, lane 4).
Hence, we conclude that the Hrs
 
 
 
N
 
 polypeptide has potent
late domain activity and can support HIV-1 Gag budding
both in cis and in trans.
In addition to rescuing VLP formation in trans, some Gag
fusion proteins with late domain activities can also rescue
the infectivity of HIV-1 proviral constructs with budding
defects (Martin-Serrano et al., 2001). For example, the wild-
type Gag–GFP protein can rescue both the budding and in-
fectivity of HIV-1 proviral constructs that harbor mutations
in the PTAP-coding region of the Gag gene. However, the
Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 construct did not efficiently rescue infec-
tivity of the R9
 
 
 
PTAP
 
 proviral construct in a single cycle repli-
cation assay (unpublished data), and we speculate that this
may reflect alterations in particle morphology caused by in-
corporation of the Hrs
 
222–777
 
 polypeptide (see below).
 
Sequence requirements for Hrs late domain activity
 
To test the sequence requirements for Hrs late domain ac-
tivity, Hrs
 
 
 
N
 
 constructs missing either the PSAP mo-
tif  (Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 
 
PSAP
 
) or the Pro/Gln-rich region
(Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 
 
C
 
) were also tested in the two VLP release
assays. As shown in Fig. 4 B, Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 
 
C
 
 was not
released from cells (Fig. 4 B, lane 5), whereas Gag
 
 
 
PTAP
 
–
Hrs
 
 
 
N
 
 
 
PSAP
 
 was released (Fig. 4 B, lane 4), but with reduced
efficiency as compared with the Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 control (27
vs. 51% total Gag protein released). Similarly, Gag
 
 
 
p6
 
 release
was not efficiently rescued in trans by the Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N
 
 
 
C
 
protein (Fig. 4 C, lane 6), although in some repetitions of
this experiment, Gag
 
 
 
p6
 
 was released at low levels (unpub-
lished data). The low levels of release, when seen, presumably
reflected weak residual late domain activity of the PSAP
sequence within the Hrs
 
 
 
N
 
 
 
C
 
 polypeptide. The Gag
 
 
 
PTAP
 
–
Hrs
 
 
 
N
 
 
 
PSAP
 
 protein again rescued the release of Gag
 
 
 
p6
 
 to
some degree (Fig. 4 C, lane 5), but was again less efficient
than Gag
 
 
 
PTAP
 
–Hrs
 
 
 
N (Fig. 4 C, compare lane 4 and lane 5).
Also, we tested the release of a Gag
 PTAP–Hrs
 N construct with
a mutation in the UIM (265LA266  → AL). This mutation
abolishes Hrs ubiquitin binding and ubiquitylation of Hrs it-
self (Polo et al., 2002), but did not diminish VLP release. In-
deed, the 265LA266 → AL mutation actually appeared to enhance
Gag
 p6–Hrs
 N release slightly (unpublished data). Overall,
we conclude that full Hrs late domain activity requires the
348PSAP351 element and COOH-terminal coiled-coil Pro/
Gln-rich region, but not the UIM. These requirements corre-
late well with the requirements for Tsg101 binding.
EM analyses of VLPs
Transmission EM was used to confirm that the Gag
 PTAP–
Hrs
 N protein was released in the form of VLPs and to ex-
amine the phenotypes of the Gag constructs that failed to
bud efficiently. In control experiments, Gag–GFP VLPs ap-
peared as enveloped, spherical particles that generally resem-
bled immature HIV virions in both appearance and size
Figure 4. Hrs can substitute for late domain functions of HIV-1 
Gag p6. (A) Summary of the Gag and Gag–Hrs fusion constructs and 
their VLP-budding phenotypes. (B) The Hrs
 N polypeptide rescues 
the budding arrest caused by mutation of the Gag PTAP late domain. 
Top, Western blot analysis of VLP release by the Gag–GFP and 
Gag–Hrs proteins. Bottom, Western blot showing cytoplasmic 
expression of the Gag–GFP and Gag–Hrs fusion proteins. 293T cells 
were transfected with 0.5  g plasmid encoding Gag–GFP (lane 1), 
Gag
 PTAP–GFP (lane 2), Gag
 PTAP–Hrs
 N (lane 3), Gag
 PTAP–Hrs
 N PSAP 
(lane 4), Gag
 PTAP–Hrs
 N C (lane 5), or empty vector (lane 6). (C) Trans 
complementation of deficient Gag
 p6 budding. Top, Western blot 
analyzing VLP release. Bottom, Western blot showing cytoplasmic 
expression of the different Gag constructs. Cells were cotransfected 
with 1.5  g plasmid DNA encoding Gag
 p6 and 0.5  g empty vector 
(lane 1), Gag–GFP (lane 2), Gag
 PTAP–GFP (lane 3), Gag
 PTAP–Hrs
 N 
(lane 4), Gag
 PTAP–Hrs
 N PSAP (lane 5), or Gag
 PTAP–Hrs
 N C (lane 6).T
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(100–200 nm in diameter; Fig. 5 A). However, the GFP
polypeptide appeared to create discontinuities in the Gag–
GFP layer, in contrast to the evenly distributed ring of Gag
density that is normally observed beneath the membranes of
immature HIV-1 virions and Gag VLPs.
As shown in Fig. 5 B, the Gag
 PTAP–Hrs
 N protein was
also released from cells in the form of enveloped VLPs that
were similar in appearance to the Gag–GFP particles, but
were larger and more heterogeneous in size (up to 500 nm in
diameter). The Gag “discontinuity” phenotype was also
quite pronounced in the Gag
 PTAP–Hrs
 N particles. Thus,
Gag
 PTAP–Hrs
 N formed enveloped VLPs as expected, but
the Hrs
 N fusion protein altered particle morphology to
some extent.
EM images of thin-sectioned cells were also examined
to determine the phenotypes of the Gag fusion proteins
that were not released efficiently (Fig. 5, C–E). In cells ex-
pressing Gag
 PTAP–GFP, Gag
 PTAP–Hrs
 N C, and Gag
 PTAP–
Hrs
 N PSAP, clusters of enveloped spherical particles associ-
ated with the cell surface were frequently observed (Fig. 5,
C–E; top images). Although it can be difficult to establish
membrane connectivities in thin-sectioned images, many of
the assembling VLPs clearly remained tethered to the plasma
membrane via thin membrane stalks (Fig. 5, C–E, arrows in
bottom images). Also, we observed images in which it ap-
peared that vacuolar structures filled with assembled VLPs
were in the process of (or had recently) fused with the
plasma membrane (unpublished data). These images sug-
gested that at least some of the VLPs budded intracellularly,
in good agreement with recent experiments showing that
HIV-1 can bud into MVB compartments in macrophages
(Raposo et al., 2002; Pelchen Matthews et al., 2003).
Overall, our EM analyses established that although the
Gag
 PTAP–GFP, Gag
 PTAP–Hrs
 N C, and Gag
 PTAP–Hrs
 N PSAP
proteins were not released from cells efficiently, they did
associate with membranes and initiate spherical particle as-
Figure 5. Electron microscopic analyses of Gag–GFP and Gag–Hrs budding. (A and B) Transmission electron micrographs of thin-sectioned 
VLPs released from 293T cells transfected with plasmids encoding Gag–GFP (A) and Gag
 PTAP–Hrs
 N (B). Note that in both cases, the proteins 
formed enveloped, spherical VLPs that resembled authentic immature virions except that (1) the electron-dense Gag layer beneath the VLP 
membrane often appeared discontinuous, suggesting that the COOH-terminal GFP and Hrs polypeptides perturbed the underlying Gag lattice; 
and (2) VLPs formed by Gag
 PTAP–Hrs
 N exhibited greater size variation and were, on average, somewhat larger than authentic immature virions. 
(C–E) Transmission electron micrographs of thin-sectioned 293T cells transfected with plasmids expressing Gag
 PTAP–GFP (C), Gag
 PTAP–Hrs
 N C 
(D), and Gag
 PTAP–Hrs
 N PSAP (E). The top images show clusters of particles associated with the cellular surface, and the bottom images 
show examples of classic “late domain” phenotypes in which the assembled particles remained tethered to the plasma membrane (or to one 
another). Bars, 100 nm.T
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sembly. Thus, the block to particle release in these con-
structs occurred at a late stage in the budding process, and
therefore reflected the defect(s) in late domain activity.
The late domain activity of Hrs is dependent on Tsg101
Next, we examined whether the late domain activity of the
Hrs
 N polypeptide required the presence of Tsg101. Cellular
Tsg101 can be efficiently depleted using RNA interference
(Garrus et al., 2001; Fig. 6, bottom, compare lane 1 and
lane 2). As shown in Fig. 6, release of Gag
 p6–Hrs
 N VLPs
from 293T cells was blocked when Tsg101 was depleted
from the producer cells (Fig. 6, top, compare lane 1 and lane
2). VLP release was restored when an exogenous RNA inter-
ference–resistant Tsg101–FLAG protein (denoted Tsg101*)
was expressed (Fig. 6, compare lane 2 and lane 3). There-
fore, this experiment confirmed that the late domain activity
of Hrs
 N is dependent on Tsg101.
As mentioned earlier in this paper, mutation of Tsg101
residue Met95 to Ala blocks the P(S/T)AP-binding activity
of the UEV domain (Pornillos et al., 2002a). Interestingly,
the Tsg101* M95A mutation also blocked the release of the
Gag–Hrs
 N protein (Fig. 6, lane 4). This absolute block was
somewhat unexpected because the Tsg101 M95A protein
could still bind Hrs (Fig. 3 C) and because the Gag
 PTAP–
Hrs
 N PSAP mutant protein was released from cells (Fig. 4 B).
However, Hrs binding was diminished by the Tsg101
M95A mutation, and VLP release was reduced by the Hrs
 PSAP
mutation, and it is therefore possible that the reduction in
Hrs binding caused by the Tsg101 M95A mutation is suffi-
cient to block VLP budding under conditions where
Tsg101* levels are limiting. Alternatively, simply recruiting
Tsg101 to the site of budding may not be sufficient to sup-
port virus budding because the NH2-terminal domain of
Tsg101 UEV may perform additional functions that are in-
hibited by the M95A mutation. In either case, the result
again emphasizes the functional significance of P(S/T)AP
binding by the UEV domain of Tsg101.
Discussion
Implications for cellular Hrs function
The molecular events underlying MVB biogenesis are of
interest because this pathway mediates a number of impor-
tant biological processes including development (Kramer,
2002), receptor down-regulation (Katzmann et al., 2002;
Sorkin and Von Zastrow, 2002), and MHC-II presentation
(Murk et al., 2002). We have shown that full-length
Tsg101 binds Hrs (and COOH-terminal fragments), and
that COOH-terminal Hrs fragments can support Tsg101-
dependent plasma membrane vesicle fission in a heterolo-
gous VLP system. These experiments, together with com-
plementary experiments from the Emr and Stenmark
laboratories (Bache et al., 2003a; Katzmann et al., 2003),
indicate that Hrs recruits Tsg101/ESCRT-I from the cyto-
plasm onto the surface of the endosome, where it interacts
with protein cargos and recruits downstream factors re-
quired for protein sorting and MVB formation. Although
analyses of the cellular pathway are clearly essential for un-
derstanding MVB biogenesis, the complementary Gag pro-
tein release assay provides an effective functional test, in
mammalian cells, for the vesicle fission activities required
for both MVB biogenesis and virus budding.
Sequential recruitment of proteins 
onto the endosomal membrane
An intriguing aspect of MVB biogenesis is that a series of
soluble complexes must be sequentially recruited from the
cytoplasm onto subdomains of the endosomal membrane
where ubiquitylated protein cargos accumulate and are even-
tually sorted into MVB vesicles. Hrs is the first of the soluble
MVB factors to bind, and its recruitment is mediated, at
least in part, by FYVE domain binding to PI(3)P molecules
displayed on the endosomal membrane (Odorizzi et al.,
1998; Urbe et al., 2000; Raiborg et al., 2001b; Katzmann et
al., 2003). Hrs localization may also be cargo-dependent
(e.g., through interactions between the Hrs UIM motif and
the ubiquitin modifications on cargo proteins; Raiborg et
al., 2002). Finally, interactions with other endosomal pro-
teins may also play important roles in Hrs localization (Urbe
et al., 2000; Raiborg et al., 2001b; Bache et al., 2002).
On the membrane, Hrs is an essential subunit of a multi-
protein complex that includes Hrs, ubiquitylated protein
cargos, STAM1, STAM2, Eps15, and clathrin (Asao et al.,
1997; Raiborg et al., 2002; Yamada et al., 2002; Bache et al.,
2003b). This complex next recruits the soluble Tsg101/ES-
CRT-I complex, and our experiments indicate that this oc-
curs, at least in part, through a direct binding interaction be-
tween Hrs and Tsg101. The nature of the “switch” that
allows Tsg101 recruitment only after Hrs is bound to the
membrane is still unclear, but plausible possibilities include
(1) avidity effects (as multiple copies of Hrs assemble at the
membrane, and Tsg101 can also oligomerize; Martin-Ser-
rano et al., 2003); (2) cooperative binding of Tsg101 to Hrs
and other endosomal membrane protein(s) (e.g., ubiquity-
lated protein cargos); and/or (3) membrane-dependent Hrs
Figure 6. Budding of Gag
 p6–Hrs
 N is dependent on the P(S/T)AP-
binding activity of Tsg101. Top, Western blot showing relative levels 
of Gag–Hrs
 N VLP release. Middle, Western blot showing cytoplasmic 
expression levels of Gag–Hrs
 N. Bottom, Anti-Tsg101 Western blot 
showing depletion of endogenous Tsg101 protein with siRNA, and 
reexpression of exogenous, siRNA-resistant Tsg101-Flag proteins 
(Tsg101*). 293T cells were cotransfected as described in the Materials 
and methods with the following exceptions: (1) lane 1 received no 
RNA; and (2) lane 5 was a mock transfection.T
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conformational changes or phosphorylation events (Urbe et
al., 2000; Bache et al., 2002).
In the next stages of MVB biogenesis, the soluble ES-
CRT-II and -III proteins are recruited from the cytoplasm
onto the membrane (Babst et al., 2002b). Again, it seems
likely that the membrane-bound ESCRT-I must be “acti-
vated” in some fashion to allow the recruitment of these
downstream factors only after ESCRT-I is bound to the
membrane.
Possible mechanisms of Tsg101 recruitment 
and activation
Unexpectedly, our binding experiments suggested that full
affinity Tsg101 binding requires at least two Hrs elements, a
first which involves the Hrs PSAP sequence binding to the
Tsg101 UEV domain, and a second that includes down-
stream Hrs elements that spans the putative coiled-coil re-
gion and at least part of the Pro/Gln-rich region. Both inter-
actions were functionally important, although mutations
that disrupted the Tsg101 UEV/PSAP interaction did not
completely eliminate complex formation and VLP budding
in all contexts, indicating that the downstream Hrs elements
may play the dominant role in Tsg101 recruitment.
The use of multiple contact sites could simply serve to in-
crease the affinity and specificity of the Hrs/Tsg101 interac-
tion. However, an attractive alternative model is that the
downstream Hrs site serves primarily to recruit Tsg101 to
sites of vesicle budding, whereas the Hrs PSAP element
serves primarily as the switch that “activates” Tsg101 for ES-
CRT-II and/or MVB cargo binding (or for other essential
events in MVB biogenesis). In this model, we envision that
the soluble cytoplasmic ESCRT-I protein may exist primar-
ily in an autoinhibited conformation in which the Tsg101
UEV domain binds its own PTAP element (i.e., in cis; Fig.
7 A). Hrs binding could then drive a conformational change
in which the Tsg101 UEV domain switches to bind the
PSAP element of Hrs (i.e., in trans). This activation event
might also involve the ubiquitin-binding site on the UEV
domain interacting with ubiquitin modifications on protein
cargos, which would provide a cooperative binding mecha-
nism for insuring that activation occurs only in the presence
of both Hrs and ubiquitylated protein cargos. Although this
model remains to be tested rigorously, we note that analo-
gous autoinhibition/conformational switching mechanisms
are used by other classes of proteins, such as protein kinases,
to create directionality in other cellular pathways (Francis et
al., 2002; Pellicena and Miller, 2002).
Viral recruitment of Tsg101
Our analyses also indicate that the structural proteins of
HIV-1, HIV-2, and Ebola have evolved to mimic the nor-
mal protein-recruiting functions of the cellular Hrs protein
in order to hijack the machinery that normally catalyzes
MVB vesicle formation and budding (Fig. 7 B). The higher
affinity P(S/T)AP element of HIV-1 Gag apparently allows
the virus to compete effectively for Tsg101 binding against
the lower affinity Hrs PSAP sequence. Viruses and cells may
also interact differently with Tsg101 because viruses have
presumably evolved to exit cells as efficiently as possible,
whereas cells must carefully regulate the flux of cargo into
MVB vesicles. This raises the intriguing possibility that by
binding tightly to the PTAP-binding site in the UEV do-
main, the virus may simultaneously recruit Tsg101 and ef-
fect a conformational change that activates the protein to
perform subsequent steps necessary for vesicle formation and
membrane fission.
Materials and methods
Plasmid constructs
A Tsg101 mammalian expression vector was constructed by fusing the
Flag epitope to the 3  end of the full-length Tsg101 gene using PCR ampli-
fication with a downstream primer encoding the Flag sequence. The am-
plified product was cloned into pIRES2-EGFP (CLONTECH Laboratories,
Inc.) to give pIRES-TsgFlag (Garrus et al., 2001). Seven silent mutations that
render pIRES-TsgFlag resistant to siRNA (denoted pIRES-Tsg*Flag) were in-
Figure 7. Models for Tsg101 recruitment and activation during 
MVB and HIV budding. (A) Model illustrating sites of Tsg101/Hrs 
interaction and a possible activation mechanism for Tsg101 (see 
text for details). Note that our data allow the possibility that other 
proteins might bridge or contribute to the interaction between the 
COOH-terminal regions of Tsg101 and Hrs. (B) Model illustrating 
how HIV Gag mimics the Tsg101-recruiting function of Hrs and 
redirects Tsg101 and the ESCRT-I complex to the plasma membrane 
to facilitate viral budding.T
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troduced into the wild-type Tsg101-coding region 413AACCTCCAG-
TCTTCTCTCGTC433 (mutated nucleotides are underlined) using Kunkel
mutagenesis (Garrus et al., 2001). N45A and M95A mutations were also
introduced into pIRES-Tsg*Flag using Kunkel mutagenesis.
All Gag and Gag–Hrs constructs were based on pGag–GFP, which con-
tains the Rev-independent HIV-1HBX2 Gag sequence fused to EGFP (Her-
mida-Matsumoto and Resh, 2000; a gift from Marilyn Resh, Sloan-Ketter-
ing Institute, New York, NY). Gag
 PTAP–GFP was created by mutating the
Gag PTAP motif to LIRL as described previously (Garrus et al., 2001).
Gag
 PTAP–Hrs fusion constructs were created from the Gag
 PTAP–GFP con-
struct by replacing the last three amino acids of Gag and the GFP-coding
region with the appropriate Hrs sequences. Gag
 p6 and Gag
 p6–Hrs con-
structs were created by replacing the p6- and GFP-coding regions with
either a stop codon or the appropriate Hrs sequences. Hrs constructs
were PCR amplified from an EST (GenBank/EMBL/DDBJ accession no.
BE276844; from American Type Culture Collection, Manassas, VA).
For yeast two-hybrid assays, Tsg101 constructs were PCR amplified
from pIRES-TsgFlag and subcloned into the plasmid MP30 (Myriad Genet-
ics), which encodes the Gal4p DNA-binding domain (BD). Hrs constructs
were subcloned into the plasmid MP29 (Myriad Genetics). The resulting
plasmids encoded in-frame fusions of Tsg101 with the Gal4p BD and of
Hrs with the Gal4p activation domain (AD). All constructs were verified by
DNA sequencing. Full cloning details are available from the authors.
Biosensor binding assays
BIAcore biosensor measurements of Tsg101 UEV binding to immobilized
GST–peptide fusion constructs were performed as described previously
(Garrus et al., 2001), and purified recombinant Tsg101 UEV domain and
GST–peptide fusion constructs were also obtained as described previously
(Jenkins et al., 2001; Pornillos et al., 2002a).
Yeast two-hybrid binding assays
Yeast strain J693 (MAT  ade2 his3 leu2 trp1 cyh2 ura3::GAL1p-LacZ gal4
gal80 lys2::GAL1p-HIS3; Bendixen et al., 1994) was cotransformed with
various pairs of BD and AD constructs (using empty BD and AD vectors as
controls), and plated on synthetic media lacking the appropriate amino ac-
ids. To identify colonies producing  -galactosidase, cells were lifted onto
filter paper disks, lysed by freeze-thawing in liquid nitrogen, and assayed
with X-gal (5-bromo-4-chloro-3-indoyl- -D-galactopyranoside). For quan-
titation of  -galactosidase activity, colonies ( 20 per plate) were selected
at random, pooled, grown on synthetic liquid media, and assayed in tripli-
cate with CPRG (chlorophenol red  -D-galactopyranoside) or ONPG
(o-nitrophenyl- -D-galactopyranoside) as described previously (Garrus et
al., 2001). These experiments were repeated a total of six times.
Tissue culture and VLP-budding assays
Human embryonic kidney 293T cells were grown in 2 ml Dulbecco’s min-
imum essential medium (6-well plates) and were transfected with expres-
sion plasmids as indicated in the figure legends using LipofectAMINE™
2000 (Invitrogen; Garrus et al., 2001). VLP-budding assays were performed
essentially as described previously (Garrus et al., 2001). In brief, plasmid
DNA encoding Gag–GFP and Gag–Hrs fusion proteins was transfected
into 293T cells. Supernatants and cytoplasmic lysates were harvested 24–
28 h later and analyzed by Western blotting (see below).
Functional siRNA knockout and rescue of Tsg101 expression were per-
formed as described previously (Elbashir et al., 2001; Garrus et al., 2001).
Synthetic 21-nt siRNA duplexes were designed to target Tsg101 at coding
nucleotides 413–433. siRNA sequences: sense, CCU CCA GUC UUC
UCU CGU CdTdT; antisense, 5  GAC GAG AGA AGA CUG GAG GdTdT.
293T cells were cotransfected twice at 24-h intervals. The first transfection
was with 50 nM siRNA duplexes and either 2  g pIRES2-EGFP or 2  g
wild-type or mutant RNAi-resistant pIRES-Tsg*Flag expression vector
(Tsg101*). The second transfection was performed with the same 50-nM
siRNA duplexes and 1  g Gag
 p6–Hrs
 N expression vector. VLP-containing
supernatants and cytoplasmic lysates were harvested after an additional
24–30 h and analyzed by Western blotting (see below).
Western blots
VLPs from 1.2 ml of supernatants from transfected cells were pelleted
through a 20% sucrose cushion in a microcentrifuge for 90 min at 13,000
rpm (4 C) and resuspended in 25–30  l of 1  SDS gel loading buffer. 5–8-
 l samples were separated by SDS-PAGE, transferred, blocked, blotted
with antisera, and protein bands were detected by ECL (Pierce Chemical
Co.). Transfected 293T cells (one well from a 6-well plate) were harvested
directly into 30–35  l RIPA buffer (10 mM TrisCl, pH 7.0, 150 mM NaCl,
1% NP-40, and 0.1% SDS) and incubated on ice for 4 min. Samples were
clarified by microcentrifugation for 4 min at 13,000 rpm (4 C), and resus-
pended in an equal volume of 2  SDS gel loading buffer. 5–8- l aliquots
were resolved by SDS-PAGE and blotted for ECL. To detect Gag proteins,
rabbit anti-HIV CA antibody (1:2,000; from Hans-Georg Krausslich,
Heidelberg, Germany) was mixed with rabbit anti-HIV MA (1:25,000; from
Didier Trono, Geneva, Switzerland). Murine monoclonal anti-Tsg101–
4A10 (1:1,000; GeneTex, Inc.) was used to detect Tsg101.
Electron microscopy
VLPs from 80 ml pooled culture supernatant were pelleted through 20%
sucrose cushions and prepared for thin-section EM as described previously
(von Schwedler et al., 1998). Cells were prepared for thin-section EM as
described previously (Garrus et al., 2001). Samples were imaged on a
transmission electron microscope (Tecnai-12; Philips).
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